Found: 15
Select item for more details and to access through your institution.
Chronic myelogenous leukemia with e13a3 (b2a3) type of BCR-ABL transcript having a DNA breakpoint between ABL exons a2 and a3.
- Published in:
- American Journal of Hematology, 2003, v. 74, n. 4, p. 268, doi. 10.1002/ajh.10429
- By:
- Publication type:
- Article
Evaluating the Efficacy of Massage Intervention for the Treatment of Poststroke Constipation: A Meta-Analysis.
- Published in:
- Evidence-based Complementary & Alternative Medicine (eCAM), 2020, p. 1, doi. 10.1155/2020/8934751
- By:
- Publication type:
- Article
Absence of Gene Mutation in TRAIL Receptor 1 (TRAIL-R1) and TRAIL Receptor 2 (TRAIL-R2) in Chronic Myelogenous Leukemia and Myelodysplastic Syndrome, and Analysis of mRNA Expressions of TRAIL and TRAIL-Related Genes in Chronic Myelogenous Leukemia.
- Published in:
- Acta Haematologica, 2005, v. 113, n. 2, p. 113, doi. 10.1159/000083449
- By:
- Publication type:
- Article
A Dihydroartemisinin‐Loaded Nanoreactor Motivates Anti‐Cancer Immunotherapy by Synergy‐Induced Ferroptosis to Activate Cgas/STING for Reprogramming of Macrophage.
- Published in:
- Advanced Healthcare Materials, 2023, v. 12, n. 28, p. 1, doi. 10.1002/adhm.202301561
- By:
- Publication type:
- Article
Clinical characteristics and drug tolerance for Pseudomonas aeruginosa infection in patients with agranulocytosis and fever in Shanghai.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Clinical characteristics and drug tolerance for Pseudomonas aeruginosa infection in patients with agranulocytosis and fever in Shanghai.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Harnessing chlorin e6 loaded by functionalized iron oxide nanoparticles linked with glucose for target photodynamic therapy and improving of the immunogenicity of lung cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 4, p. 867, doi. 10.1007/s00432-021-03879-x
- By:
- Publication type:
- Article
Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemia.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-020-20259-0
- By:
- Publication type:
- Article
Metal-organic framework-encapsulated dihydroartemisinin nanoparticles induces apoptotic cell death in ovarian cancer by blocking ROMO1-mediated ROS production.
- Published in:
- Journal of Nanobiotechnology, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12951-023-01959-3
- By:
- Publication type:
- Article
Dihydroartemisinin remodels macrophage into an M1 phenotype via ferroptosis-mediated DNA damage.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.949835
- By:
- Publication type:
- Article
Chlorin e6-Induced Photodynamic Effect Polarizes the Macrophage Into an M1 Phenotype Through Oxidative DNA Damage and Activation of STING.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.837784
- By:
- Publication type:
- Article
High-dose methotrexate, etoposide, dexamethasone and pegaspargase (MEDA) combination chemotherapy is effective for advanced and relapsed/refractory extranodal natural killer/T cell lymphoma: a retrospective study.
- Published in:
- International Journal of Hematology, 2015, v. 102, n. 2, p. 181, doi. 10.1007/s12185-015-1809-x
- By:
- Publication type:
- Article
Dihydroartemisinin‐driven TOM70 inhibition leads to mitochondrial destabilization to induce pyroptosis against lung cancer.
- Published in:
- Phytotherapy Research, 2024, v. 38, n. 8, p. 3856, doi. 10.1002/ptr.8242
- By:
- Publication type:
- Article
Determining M2 macrophages content for the anti-tumor effects of metal-organic framework-encapsulated pazopanib nanoparticles in breast cancer.
- Published in:
- Journal of Nanobiotechnology, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12951-024-02694-z
- By:
- Publication type:
- Article
A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin.
- Published in:
- Journal of Nanobiotechnology, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12951-022-01455-0
- By:
- Publication type:
- Article